MPAA Motorcar Parts of America | $7.91
+1.3% | 12/20/2024 | Initiated by | Cantor Fitzgerald | Analyst D. Soderberg | Overweight | $14.00 | N/A | View details for Cantor Fitzgerald rating of Motorcar Parts of America (NASDAQ:MPAA) on 12/20/2024 |
APLD Applied Digital | $8.01
-0.5% | 12/20/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | $15.00 | N/A | View details for Cantor Fitzgerald rating of Applied Digital (NASDAQ:APLD) on 12/20/2024 |
CGNX Cognex | $35.77
-0.8% | 12/19/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $49.00 | N/A | View details for Cantor Fitzgerald rating of Cognex (NASDAQ:CGNX) on 12/19/2024 |
MU Micron Technology | $90.12
+3.5% | 12/19/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $150.00 -> $130.00 | N/A | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 12/19/2024 |
PACK Ranpak | $7.13
-0.1% | 12/19/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $11.50 | N/A | View details for Cantor Fitzgerald rating of Ranpak (NYSE:PACK) on 12/19/2024 |
UBER Uber Technologies | $60.73
+0.9% | 12/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $90.00 -> $90.00 | N/A | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 12/18/2024 |
|
AGIO Agios Pharmaceuticals | $35.42
-1.1% | 12/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 12/18/2024 |
ALXO ALX Oncology | $1.62
+9.5% | 12/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 12/18/2024 |
PVLA Palvella Therapeutics | $12.05
+0.4% | 12/18/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | | N/A | View details for Cantor Fitzgerald rating of Palvella Therapeutics (NASDAQ:PVLA) on 12/18/2024 |
ACHR Archer Aviation | $9.49
+12.7% | 12/18/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $13.00 | N/A | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 12/18/2024 |
IDYA IDEAYA Biosciences | $25.61
+3.3% | 12/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of IDEAYA Biosciences (NASDAQ:IDYA) on 12/17/2024 |
BHVN Biohaven | $36.26
+2.6% | 12/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 12/17/2024 |
TLSI TriSalus Life Sciences | $4.05
+12.5% | 12/17/2024 | Initiated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight | $10.00 | N/A | View details for Cantor Fitzgerald rating of TriSalus Life Sciences (NASDAQ:TLSI) on 12/17/2024 |
ESPR Esperion Therapeutics | $2.19
+0.9% | 12/17/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Esperion Therapeutics (NASDAQ:ESPR) on 12/17/2024 |
AQST Aquestive Therapeutics | $3.65
+0.3% | 12/17/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $17.00 | N/A | View details for Cantor Fitzgerald rating of Aquestive Therapeutics (NASDAQ:AQST) on 12/17/2024 |
ARCT Arcturus Therapeutics | $15.48
+4.3% | 12/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Arcturus Therapeutics (NASDAQ:ARCT) on 12/16/2024 |
AXSM Axsome Therapeutics | $90.73
+1.1% | 12/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $121.00 -> $121.00 | N/A | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 12/12/2024 |
BMRN BioMarin Pharmaceutical | $65.66
+1.0% | 12/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 -> $90.00 | N/A | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 12/12/2024 |
GILD Gilead Sciences | $92.57
+1.6% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $80.00 -> $80.00 | N/A | View details for Cantor Fitzgerald rating of Gilead Sciences (NASDAQ:GILD) on 12/11/2024 |
CNC Centene | $59.58
-0.2% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 -> $90.00 | N/A | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 12/11/2024 |
ZURA Zura Bio | $2.28
-2.6% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Zura Bio (NASDAQ:ZURA) on 12/11/2024 |
TRML Tourmaline Bio | $20.65
+1.5% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $25.00 -> $25.00 | N/A | View details for Cantor Fitzgerald rating of Tourmaline Bio (NASDAQ:TRML) on 12/11/2024 |
JANX Janux Therapeutics | $56.83
+0.1% | 12/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $200.00 -> $200.00 | N/A | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 12/11/2024 |
BEAM Beam Therapeutics | $29.01
+8.0% | 12/10/2024 | Upgraded by | Cantor Fitzgerald | Analyst R. Bienkowski | Hold | | N/A | View details for Cantor Fitzgerald rating of Beam Therapeutics (NASDAQ:BEAM) on 12/10/2024 |
QURE uniQure | $16.98
+9.8% | 12/10/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 -> $58.00 | N/A | View details for Cantor Fitzgerald rating of uniQure (NASDAQ:QURE) on 12/10/2024 |
RIGL Rigel Pharmaceuticals | $17.09
-0.7% | 12/10/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $15.00 -> $25.00 | N/A | View details for Cantor Fitzgerald rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 12/10/2024 |
STOK Stoke Therapeutics | $11.68
+3.4% | 12/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Stoke Therapeutics (NASDAQ:STOK) on 12/10/2024 |
TSLA Tesla | $421.06
-3.5% | 12/10/2024 | Target Raised by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $255.00 -> $365.00 | N/A | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 12/10/2024 |
ACHC Acadia Healthcare | $37.90
-1.8% | 12/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $52.00 -> $52.00 | N/A | View details for Cantor Fitzgerald rating of Acadia Healthcare (NASDAQ:ACHC) on 12/10/2024 |
AUR Aurora Innovation | $7.19
+0.1% | 12/10/2024 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $10.00 | N/A | View details for Cantor Fitzgerald rating of Aurora Innovation (NASDAQ:AUR) on 12/10/2024 |
HUT Hut 8 | C$34.00
-0.6% | 12/9/2024 | Upgraded by | Cantor Fitzgerald | Analyst B. Knoblauch | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Hut 8 (TSE:HUT) on 12/9/2024 |
MREO Mereo BioPharma Group | $3.35
+1.8% | 12/8/2024 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 12/8/2024 |
KALV KalVista Pharmaceuticals | $8.36
+3.3% | 12/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 12/9/2024 |
KURA Kura Oncology | $9.01
+0.4% | 12/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Kura Oncology (NASDAQ:KURA) on 12/9/2024 |
LEGN Legend Biotech | $34.08
+0.2% | 12/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $83.00 -> $83.00 | N/A | View details for Cantor Fitzgerald rating of Legend Biotech (NASDAQ:LEGN) on 12/9/2024 |
HUT Hut 8 | $23.68
-0.5% | 12/9/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $35.00 -> $35.00 | N/A | View details for Cantor Fitzgerald rating of Hut 8 (NASDAQ:HUT) on 12/9/2024 |
NNOX Nano-X Imaging | $6.76
+2.9% | 12/6/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $12.00 | N/A | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 12/6/2024 |
GTLB GitLab | $59.83
+7.5% | 12/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $75.00 -> $80.00 | N/A | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 12/6/2024 |
RBRK Rubrik | $66.12
-1.3% | 12/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $58.00 -> $70.00 | N/A | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 12/6/2024 |
CXM Sprinklr | $9.10
-0.5% | 12/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Neutral -> Neutral | $9.00 -> $9.00 | N/A | View details for Cantor Fitzgerald rating of Sprinklr (NYSE:CXM) on 12/5/2024 |
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] |
COUR Coursera | $8.31
-1.1% | 12/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $10.00 -> $10.00 | N/A | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 12/5/2024 |
RZLV Rezolve AI | $2.96
-2.6% | 12/5/2024 | Initiated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight | $5.00 | N/A | View details for Cantor Fitzgerald rating of Rezolve AI (NASDAQ:RZLV) on 12/5/2024 |
TNGX Tango Therapeutics | $3.10
+5.4% | 12/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Tango Therapeutics (NASDAQ:TNGX) on 12/5/2024 |
WULF TeraWulf | $6.61
+1.8% | 12/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $11.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 12/4/2024 |
PRE Prenetics Global | $5.64
+2.9% | 12/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $9.00 -> $9.00 | N/A | View details for Cantor Fitzgerald rating of Prenetics Global (NASDAQ:PRE) on 12/4/2024 |
MRVL Marvell Technology | $111.90
+2.6% | 12/4/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $120.00 -> $135.00 | N/A | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 12/4/2024 |
RNAC Cartesian Therapeutics | $19.02
-1.3% | 12/2/2024 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Hold | | N/A | View details for Cantor Fitzgerald rating of Cartesian Therapeutics (NASDAQ:RNAC) on 12/2/2024 |
IREN Iris Energy | $11.81
+3.5% | 11/27/2024 | Target Raised by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $20.00 -> $23.00 | N/A | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 11/27/2024 |
PSTX Poseida Therapeutics | $9.45
+0.4% | 11/26/2024 | Downgraded by | Cantor Fitzgerald | Analyst J. Kim | Strong-Buy -> Hold | | N/A | View details for Cantor Fitzgerald rating of Poseida Therapeutics (NASDAQ:PSTX) on 11/26/2024 |
NNOX Nano-X Imaging | $6.76
+2.9% | 11/26/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 11/26/2024 |
ALEC Alector | $1.86
+4.5% | 11/26/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Alector (NASDAQ:ALEC) on 11/26/2024 |
WDC Western Digital | $60.24
+1.0% | 11/26/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $95.00 -> $95.00 | N/A | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 11/26/2024 |
KRNT Kornit Digital | $32.60
+1.5% | 11/26/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $39.00 | N/A | View details for Cantor Fitzgerald rating of Kornit Digital (NASDAQ:KRNT) on 11/26/2024 |
KROS Keros Therapeutics | $17.03
+0.7% | 11/22/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | N/A | View details for Cantor Fitzgerald rating of Keros Therapeutics (NASDAQ:KROS) on 11/22/2024 |
CDXS Codexis | $5.28
+3.1% | 11/22/2024 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $11.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of Codexis (NASDAQ:CDXS) on 11/22/2024 |
RBRK Rubrik | $66.12
-1.3% | 11/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 11/20/2024 |
CRWD CrowdStrike | $362.29
+3.2% | 11/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 11/20/2024 |
CRWD CrowdStrike | $362.29
+3.2% | 11/21/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $350.00 -> $370.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 11/21/2024 |
WIX Wix.com | $221.37
+1.8% | 11/21/2024 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $200.00 -> $240.00 | N/A | View details for Cantor Fitzgerald rating of Wix.com (NASDAQ:WIX) on 11/21/2024 |
NVDA NVIDIA | $134.70
+3.1% | 11/21/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $175.00 -> $175.00 | N/A | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 11/21/2024 |
KURA Kura Oncology | $9.01
+0.4% | 11/21/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Kura Oncology (NASDAQ:KURA) on 11/21/2024 |
PANW Palo Alto Networks | $186.78
-1.4% | 11/21/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $222.50 -> $222.50 | N/A | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 11/21/2024 |
ACRS Aclaris Therapeutics | $2.72
-1.8% | 11/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst L. Chen | Neutral -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/20/2024 |
MDGL Madrigal Pharmaceuticals | $308.44
+5.1% | 11/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Neutral | | N/A | View details for Cantor Fitzgerald rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 11/20/2024 |
QCOM QUALCOMM | $152.89
+1.7% | 11/20/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $160.00 -> $160.00 | N/A | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 11/20/2024 |
ZS Zscaler | $187.38
+2.3% | 11/18/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Hold | | N/A | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 11/18/2024 |
HIVE HIVE Digital Technologies | $3.13
-0.3% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $9.00 -> $9.00 | N/A | View details for Cantor Fitzgerald rating of HIVE Digital Technologies (NASDAQ:HIVE) on 11/19/2024 |
RCKT Rocket Pharmaceuticals | $11.56
+1.9% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 -> $65.00 | N/A | View details for Cantor Fitzgerald rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 11/19/2024 |
AFMD Affimed | $1.19
+0.8% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Affimed (NASDAQ:AFMD) on 11/19/2024 |
PCT PureCycle Technologies | $10.85
+4.6% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $14.00 | N/A | View details for Cantor Fitzgerald rating of PureCycle Technologies (NASDAQ:PCT) on 11/19/2024 |
INCY Incyte | $68.84
+2.7% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral | | N/A | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 11/19/2024 |
FTNT Fortinet | $97.19
+2.5% | 11/19/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $88.00 -> $95.00 | N/A | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 11/19/2024 |
SYM Symbotic | $23.99
+4.1% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 -> $60.00 | N/A | View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 11/19/2024 |
SEPN Septerna | $24.28
+3.8% | 11/19/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | $50.00 | N/A | View details for Cantor Fitzgerald rating of Septerna (NASDAQ:SEPN) on 11/19/2024 |
SSTI SoundThinking | $12.33
+0.3% | 11/14/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 11/14/2024 |
CDXS Codexis | $5.28
+3.1% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $11.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of Codexis (NASDAQ:CDXS) on 11/15/2024 |
AMAT Applied Materials | $163.59
+1.3% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $250.00 -> $250.00 | N/A | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 11/15/2024 |
ASND Ascendis Pharma A/S | $136.38
-1.0% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $170.00 -> $170.00 | N/A | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/15/2024 |
ELUT Elutia | $4.84
+37.1% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | N/A | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 11/15/2024 |
LUCD Lucid Diagnostics | $0.78
+1.3% | 11/15/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 -> $2.00 | N/A | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 11/15/2024 |
ANNX Annexon | $5.23
+0.2% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 11/15/2024 |
SPRO Spero Therapeutics | $0.96
-4.3% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Spero Therapeutics (NASDAQ:SPRO) on 11/15/2024 |
LUNR Intuitive Machines | $13.57
+6.2% | 11/15/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $15.00 | N/A | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 11/15/2024 |
OMER Omeros | $10.31
+0.7% | 11/14/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral | | N/A | View details for Cantor Fitzgerald rating of Omeros (NASDAQ:OMER) on 11/14/2024 |
CSLR Complete Solaria | $1.54
| 11/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $6.00 | N/A | View details for Cantor Fitzgerald rating of Complete Solaria (NASDAQ:CSLR) on 11/14/2024 |
RKLB Rocket Lab USA | $24.87
+7.1% | 11/14/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $24.00 | N/A | View details for Cantor Fitzgerald rating of Rocket Lab USA (NASDAQ:RKLB) on 11/14/2024 |
CYBR CyberArk Software | $319.15
+1.3% | 11/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $335.00 -> $335.00 | N/A | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 11/14/2024 |
MRNS Marinus Pharmaceuticals | $0.23
-3.6% | 11/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 -> $4.00 | N/A | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 11/14/2024 |
ALMS Alumis | $8.82
+2.2% | 11/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | N/A | View details for Cantor Fitzgerald rating of Alumis (NASDAQ:ALMS) on 11/14/2024 |
CAPR Capricor Therapeutics | $13.07
+1.3% | 11/14/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 -> $30.00 | N/A | View details for Cantor Fitzgerald rating of Capricor Therapeutics (NASDAQ:CAPR) on 11/14/2024 |
Your chance to get on the next “60-Second Trade” (Ad) Ever heard of the “60-Second Trade”?
It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days…
In on Monday, out on Friday! Just head over here! |
INVZ Innoviz Technologies | $1.15
+9.5% | 11/14/2024 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | | N/A | View details for Cantor Fitzgerald rating of Innoviz Technologies (NASDAQ:INVZ) on 11/14/2024 |
GTLB GitLab | $59.83
+7.5% | 11/12/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 11/12/2024 |
TSHA Taysha Gene Therapies | $1.85
| 11/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $7.00 | N/A | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 11/12/2024 |
ALXO ALX Oncology | $1.62
+9.5% | 11/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 11/12/2024 |
OUST Ouster | $11.98
+15.0% | 11/11/2024 | Upgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Overweight | $12.00 -> $10.00 | N/A | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 11/11/2024 |
CDE Coeur Mining | $5.88
+1.9% | 11/7/2024 | Upgraded by | Cantor Fitzgerald | Analyst M. Kozak | Hold -> Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Coeur Mining (NYSE:CDE) on 11/7/2024 |
NRDY Nerdy | $1.71
+6.9% | 11/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Neutral | $6.00 -> $1.00 | N/A | View details for Cantor Fitzgerald rating of Nerdy (NYSE:NRDY) on 11/8/2024 |
FOLD Amicus Therapeutics | $9.80
+0.7% | 11/7/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 -> $21.00 | N/A | View details for Cantor Fitzgerald rating of Amicus Therapeutics (NASDAQ:FOLD) on 11/7/2024 |
LYFT Lyft | $13.57
-0.1% | 11/7/2024 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $13.00 -> $16.00 | N/A | View details for Cantor Fitzgerald rating of Lyft (NASDAQ:LYFT) on 11/7/2024 |
MELI MercadoLibre | $1,720.36
+3.3% | 11/7/2024 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $2,530.00 -> $2,300.00 | N/A | View details for Cantor Fitzgerald rating of MercadoLibre (NASDAQ:MELI) on 11/7/2024 |
TRIP Tripadvisor | $13.79
-0.7% | 11/7/2024 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Underweight -> Underweight | $12.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of Tripadvisor (NASDAQ:TRIP) on 11/7/2024 |
QCOM QUALCOMM | $152.89
+1.7% | 11/7/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $160.00 -> $160.00 | N/A | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 11/7/2024 |
KVYO Klaviyo | $44.08
+3.0% | 11/7/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $33.00 -> $47.00 | N/A | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 11/7/2024 |
JANX Janux Therapeutics | $56.83
+0.1% | 11/7/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $100.00 -> $100.00 | N/A | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 11/7/2024 |
GILD Gilead Sciences | $92.57
+1.6% | 11/7/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $70.00 -> $80.00 | N/A | View details for Cantor Fitzgerald rating of Gilead Sciences (NASDAQ:GILD) on 11/7/2024 |
SRPT Sarepta Therapeutics | $118.97
-0.4% | 11/7/2024 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Neutral -> Overweight | $152.00 -> $167.00 | N/A | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/7/2024 |
QURE uniQure | $16.98
+9.8% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 -> $28.00 | N/A | View details for Cantor Fitzgerald rating of uniQure (NASDAQ:QURE) on 11/6/2024 |
PCVX Vaxcyte | $86.53
+0.4% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Vaxcyte (NASDAQ:PCVX) on 11/6/2024 |
BBAI BigBear.ai | $3.11
+10.3% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | $3.50 | N/A | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 11/6/2024 |
NVO Novo Nordisk A/S | $85.00
-17.8% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $160.00 -> $160.00 | N/A | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 11/6/2024 |
GFS GlobalFoundries | $41.72
+1.0% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $40.00 -> $40.00 | N/A | View details for Cantor Fitzgerald rating of GlobalFoundries (NASDAQ:GFS) on 11/6/2024 |
KURA Kura Oncology | $9.01
+0.4% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Kura Oncology (NASDAQ:KURA) on 11/6/2024 |
XMTR Xometry | $41.67
+13.9% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Underweight -> Underweight | $12.00 | N/A | View details for Cantor Fitzgerald rating of Xometry (NASDAQ:XMTR) on 11/6/2024 |
RARE Ultragenyx Pharmaceutical | $44.22
+1.7% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $116.00 -> $116.00 | N/A | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 11/6/2024 |
EVEX EVE | $5.01
+8.4% | 11/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $5.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of EVE (NYSE:EVEX) on 11/5/2024 |
NYXH Nyxoah | $8.01
+0.1% | 11/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 -> $16.00 | Medium | View details for Cantor Fitzgerald rating of Nyxoah (NASDAQ:NYXH) on 11/5/2024 |
VRTX Vertex Pharmaceuticals | $397.27
+0.2% | 11/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $480.00 -> $480.00 | Medium | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 11/5/2024 |
ASND Ascendis Pharma A/S | $136.38
-1.0% | 11/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $170.00 -> $170.00 | High | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/4/2024 |
NXPI NXP Semiconductors | $210.24
+1.4% | 11/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $270.00 -> $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 11/4/2024 |
PRLB Proto Labs | $40.72
-1.3% | 11/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $40.00 -> $40.00 | High | View details for Cantor Fitzgerald rating of Proto Labs (NYSE:PRLB) on 11/4/2024 |
PANW Palo Alto Networks | $186.78
-1.4% | 11/1/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 11/1/2024 |
PANW Palo Alto Networks | $186.78
-1.4% | 10/31/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $200.00 -> $207.50 | Low | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 10/31/2024 |
AMD Advanced Micro Devices | $119.21
+0.3% | 10/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 -> $180.00 | Medium | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 10/30/2024 |
BMRN BioMarin Pharmaceutical | $65.66
+1.0% | 10/30/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $110.00 -> $90.00 | High | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 10/30/2024 |
SNAP Snap | $11.40
+0.9% | 10/30/2024 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $8.00 -> $9.00 | Low | View details for Cantor Fitzgerald rating of Snap (NYSE:SNAP) on 10/30/2024 |
GOOGL Alphabet | $191.41
+1.5% | 10/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $190.00 -> $190.00 | High | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 10/30/2024 |
IREN Iris Energy | $11.81
+3.5% | 10/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $20.00 -> $20.00 | Medium | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 10/30/2024 |
HRMY Harmony Biosciences | $34.28
+1.2% | 10/30/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $51.00 -> $58.00 | High | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 10/30/2024 |
THC Tenet Healthcare | $129.46
+3.0% | 10/30/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $168.00 -> $177.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 10/30/2024 |
ENVX Enovix | $9.73
+21.2% | 10/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 10/30/2024 |
UDMY Udemy | $7.90
+1.8% | 10/30/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $18.00 -> $11.00 | High | View details for Cantor Fitzgerald rating of Udemy (NASDAQ:UDMY) on 10/30/2024 |
ABEO Abeona Therapeutics | $5.70
+1.2% | 10/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $18.00 -> $18.00 | High | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 10/29/2024 |
FROG JFrog | $30.86
+1.0% | 10/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight | $35.00 | Low | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 10/29/2024 |
FTNT Fortinet | $97.19
+2.5% | 10/29/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 -> $88.00 | Medium | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 10/29/2024 |
CYBR CyberArk Software | $319.15
+1.3% | 10/29/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $300.00 -> $335.00 | High | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 10/29/2024 |
HIVE HIVE Digital Technologies | $3.13
-0.3% | 10/29/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | $9.00 | Low | View details for Cantor Fitzgerald rating of HIVE Digital Technologies (NASDAQ:HIVE) on 10/29/2024 |
ZLAB Zai Lab | $26.72
+1.9% | 10/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 10/25/2024 |
WDC Western Digital | $60.24
+1.0% | 10/25/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $80.00 -> $95.00 | High | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 10/25/2024 |
COUR Coursera | $8.31
-1.1% | 10/25/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $22.00 -> $10.00 | Medium | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 10/25/2024 |
ALKS Alkermes | $29.71
-0.9% | 10/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 -> $43.00 | Medium | View details for Cantor Fitzgerald rating of Alkermes (NASDAQ:ALKS) on 10/25/2024 |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
UHS Universal Health Services | $180.11
+2.5% | 10/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Neutral -> Neutral | $219.00 -> $219.00 | Medium | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 10/25/2024 |
MRNS Marinus Pharmaceuticals | $0.23
-3.6% | 10/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $4.00 | High | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 10/25/2024 |
LRCX Lam Research | $71.79
+0.8% | 10/24/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $100.00 -> $100.00 | Medium | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 10/24/2024 |
PI Impinj | $149.83
+5.0% | 10/24/2024 | Target Raised by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $205.00 -> $260.00 | High | View details for Cantor Fitzgerald rating of Impinj (NASDAQ:PI) on 10/24/2024 |
MOH Molina Healthcare | $294.73
+0.4% | 10/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $406.00 -> $406.00 | High | View details for Cantor Fitzgerald rating of Molina Healthcare (NYSE:MOH) on 10/24/2024 |
KROS Keros Therapeutics | $17.03
+0.7% | 10/24/2024 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | High | View details for Cantor Fitzgerald rating of Keros Therapeutics (NASDAQ:KROS) on 10/24/2024 |
CI The Cigna Group | $276.92
+0.8% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $400.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 10/23/2024 |
TXN Texas Instruments | $186.87
+1.3% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $200.00 -> $200.00 | Medium | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 10/23/2024 |
TSLA Tesla | $421.06
-3.5% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $245.00 -> $245.00 | Low | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 10/23/2024 |
BHVN Biohaven | $36.26
+2.6% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Medium | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 10/23/2024 |
CVRX CVRx | $12.11
+3.3% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $14.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of CVRx (NASDAQ:CVRX) on 10/23/2024 |
STX Seagate Technology | $87.31
-0.3% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $125.00 -> $125.00 | Medium | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 10/23/2024 |
REGN Regeneron Pharmaceuticals | $701.85
-0.9% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $1,015.00 -> $1,015.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 10/23/2024 |
PFE Pfizer | $26.36
+2.3% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 10/23/2024 |
AMGN Amgen | $263.38
+0.8% | 10/22/2024 | Reiterated by | Cantor Fitzgerald | Analyst O. Brayer | Overweight -> Overweight | $405.00 -> $405.00 | High | View details for Cantor Fitzgerald rating of Amgen (NASDAQ:AMGN) on 10/22/2024 |
RARE Ultragenyx Pharmaceutical | $44.22
+1.7% | 10/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $116.00 -> $116.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 10/22/2024 |
BMY Bristol-Myers Squibb | $57.33
+1.8% | 10/18/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $50.00 -> $50.00 | Low | View details for Cantor Fitzgerald rating of Bristol-Myers Squibb (NYSE:BMY) on 10/18/2024 |
VSTM Verastem | $4.19
-5.6% | 10/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | High | View details for Cantor Fitzgerald rating of Verastem (NASDAQ:VSTM) on 10/18/2024 |
CYTK Cytokinetics | $48.87
+4.6% | 10/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | High | View details for Cantor Fitzgerald rating of Cytokinetics (NASDAQ:CYTK) on 10/18/2024 |
ELV Elevance Health | $365.96
-0.1% | 10/18/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $600.00 -> $485.00 | Medium | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 10/18/2024 |
ZURA Zura Bio | $2.28
-2.6% | 10/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | | Low | View details for Cantor Fitzgerald rating of Zura Bio (NASDAQ:ZURA) on 10/18/2024 |
PCT PureCycle Technologies | $10.85
+4.6% | 10/18/2024 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $14.00 | High | View details for Cantor Fitzgerald rating of PureCycle Technologies (NASDAQ:PCT) on 10/18/2024 |
UNH UnitedHealth Group | $500.13
+2.2% | 10/16/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 -> $644.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 10/16/2024 |
JNJ Johnson & Johnson | $144.47
+0.6% | 10/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $215.00 -> $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 10/16/2024 |
META Meta Platforms | $585.25
-1.7% | 10/16/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $670.00 -> $670.00 | Low | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 10/16/2024 |
TRML Tourmaline Bio | $20.65
+1.5% | 10/15/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Schimmer | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Tourmaline Bio (NASDAQ:TRML) on 10/15/2024 |
IRON Disc Medicine | $64.50
+2.5% | 10/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $85.00 -> $85.00 | Low | View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 10/15/2024 |
IDYA IDEAYA Biosciences | $25.61
+3.3% | 10/15/2024 | Initiated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | Medium | View details for Cantor Fitzgerald rating of IDEAYA Biosciences (NASDAQ:IDYA) on 10/15/2024 |
LMAT LeMaitre Vascular | $92.12
-0.1% | 10/15/2024 | Initiated by | Cantor Fitzgerald | Analyst R. Osborn | Neutral | $96.00 | Medium | View details for Cantor Fitzgerald rating of LeMaitre Vascular (NASDAQ:LMAT) on 10/15/2024 |
LBPH Longboard Pharmaceuticals | $59.98
+0.0% | 10/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Neutral | | High | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 10/14/2024 |
ZVRA Zevra Therapeutics | $8.49
-0.6% | 10/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 10/11/2024 |
MDGL Madrigal Pharmaceuticals | $308.44
+5.1% | 10/11/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Neutral | | Low | View details for Cantor Fitzgerald rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 10/11/2024 |
SYM Symbotic | $23.99
+4.1% | 10/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 -> $60.00 | Medium | View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 10/11/2024 |
ALNY Alnylam Pharmaceuticals | $245.44
+2.8% | 10/11/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $220.00 -> $220.00 | Low | View details for Cantor Fitzgerald rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 10/11/2024 |
JNJ Johnson & Johnson | $144.47
+0.6% | 10/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $215.00 -> $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 10/10/2024 |
ALKS Alkermes | $29.71
-0.9% | 10/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 -> $48.00 | High | View details for Cantor Fitzgerald rating of Alkermes (NASDAQ:ALKS) on 10/10/2024 |
NVO Novo Nordisk A/S | $85.00
-17.8% | 10/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $160.00 -> $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 10/10/2024 |
MARA MARA | $19.96
-2.0% | 10/10/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | $21.00 | Low | View details for Cantor Fitzgerald rating of MARA (NASDAQ:MARA) on 10/10/2024 |
AVGO Broadcom | $220.79
+1.1% | 10/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $200.00 -> $225.00 | Low | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 10/8/2024 |
GFS GlobalFoundries | $41.72
+1.0% | 10/8/2024 | Target Lowered by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $55.00 -> $40.00 | Low | View details for Cantor Fitzgerald rating of GlobalFoundries (NASDAQ:GFS) on 10/8/2024 |
NXPI NXP Semiconductors | $210.24
+1.4% | 10/8/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $350.00 -> $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 10/8/2024 |
QCOM QUALCOMM | $152.89
+1.7% | 10/8/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $215.00 -> $160.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 10/8/2024 |
TXN Texas Instruments | $186.87
+1.3% | 10/8/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $210.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 10/8/2024 |
ADI Analog Devices | $211.78
+1.9% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $250.00 -> $250.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 10/8/2024 |
AMAT Applied Materials | $163.59
+1.3% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $250.00 -> $250.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 10/8/2024 |
KLAC KLA | $629.37
+1.2% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $925.00 -> $925.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 10/8/2024 |
NVDA NVIDIA | $134.70
+3.1% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $175.00 -> $175.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 10/8/2024 |
LCID Lucid Group | $3.02
+14.8% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $4.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 10/8/2024 |
SPRY ARS Pharmaceuticals | $11.18
-1.2% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $30.00 -> $30.00 | Low | View details for Cantor Fitzgerald rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 10/8/2024 |
VRTX Vertex Pharmaceuticals | $397.27
+0.2% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $480.00 -> $480.00 | Medium | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 10/8/2024 |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
BCAX Bicara Therapeutics | $17.59
+6.0% | 10/8/2024 | Initiated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | High | View details for Cantor Fitzgerald rating of Bicara Therapeutics (NASDAQ:BCAX) on 10/8/2024 |
ACHR Archer Aviation | $9.49
+12.7% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | High | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 10/7/2024 |
UBER Uber Technologies | $60.73
+0.9% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $90.00 -> $90.00 | Low | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 10/7/2024 |
WIX Wix.com | $221.37
+1.8% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $200.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of Wix.com (NASDAQ:WIX) on 10/7/2024 |
ZG Zillow Group | $73.77
+3.0% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $47.00 -> $47.00 | Low | View details for Cantor Fitzgerald rating of Zillow Group (NASDAQ:ZG) on 10/7/2024 |
SPOT Spotify Technology | $460.88
+1.5% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $340.00 -> $340.00 | Medium | View details for Cantor Fitzgerald rating of Spotify Technology (NYSE:SPOT) on 10/7/2024 |
TRIP Tripadvisor | $13.79
-0.7% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Underweight -> Underweight | $12.00 -> $12.00 | Low | View details for Cantor Fitzgerald rating of Tripadvisor (NASDAQ:TRIP) on 10/7/2024 |
TTD Trade Desk | $125.01
-1.0% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $110.00 -> $110.00 | Low | View details for Cantor Fitzgerald rating of Trade Desk (NASDAQ:TTD) on 10/7/2024 |
PINS Pinterest | $29.49
-0.4% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $41.00 -> $41.00 | Low | View details for Cantor Fitzgerald rating of Pinterest (NYSE:PINS) on 10/7/2024 |
SHOP Shopify | $108.95
+1.8% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $70.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of Shopify (NYSE:SHOP) on 10/7/2024 |
SNAP Snap | $11.40
+0.9% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $8.00 -> $8.00 | Medium | View details for Cantor Fitzgerald rating of Snap (NYSE:SNAP) on 10/7/2024 |
AMD Advanced Micro Devices | $119.21
+0.3% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 -> $180.00 | Medium | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 10/7/2024 |
TSLA Tesla | $421.06
-3.5% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $245.00 -> $245.00 | Low | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 10/7/2024 |
ABNB Airbnb | $134.21
+3.8% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Underweight -> Underweight | $94.00 -> $94.00 | Low | View details for Cantor Fitzgerald rating of Airbnb (NASDAQ:ABNB) on 10/7/2024 |
AMZN Amazon.com | $224.92
+0.7% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $230.00 -> $230.00 | Low | View details for Cantor Fitzgerald rating of Amazon.com (NASDAQ:AMZN) on 10/7/2024 |
BKNG Booking | $5,048.59
+1.4% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $3,590.00 -> $3,590.00 | High | View details for Cantor Fitzgerald rating of Booking (NASDAQ:BKNG) on 10/7/2024 |
CART Maplebear | $42.02
-0.1% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $45.00 -> $45.00 | Medium | View details for Cantor Fitzgerald rating of Maplebear (NASDAQ:CART) on 10/7/2024 |
DASH DoorDash | $171.00
+2.0% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $160.00 -> $160.00 | Low | View details for Cantor Fitzgerald rating of DoorDash (NASDAQ:DASH) on 10/7/2024 |
EBAY eBay | $65.01
+1.7% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $62.00 -> $62.00 | Low | View details for Cantor Fitzgerald rating of eBay (NASDAQ:EBAY) on 10/7/2024 |
ETSY Etsy | $56.81
-0.6% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $50.00 -> $50.00 | Medium | View details for Cantor Fitzgerald rating of Etsy (NASDAQ:ETSY) on 10/7/2024 |
EXPE Expedia Group | $184.75
+3.0% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $130.00 -> $130.00 | Low | View details for Cantor Fitzgerald rating of Expedia Group (NASDAQ:EXPE) on 10/7/2024 |
GDDY GoDaddy | $205.41
+1.2% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $170.00 -> $170.00 | Medium | View details for Cantor Fitzgerald rating of GoDaddy (NYSE:GDDY) on 10/7/2024 |
GOOGL Alphabet | $191.41
+1.5% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $190.00 -> $190.00 | High | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 10/7/2024 |
LYFT Lyft | $13.57
-0.1% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $13.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Lyft (NASDAQ:LYFT) on 10/7/2024 |
MELI MercadoLibre | $1,720.36
+3.3% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $2,530.00 -> $2,530.00 | Low | View details for Cantor Fitzgerald rating of MercadoLibre (NASDAQ:MELI) on 10/7/2024 |
META Meta Platforms | $585.25
-1.7% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $660.00 -> $660.00 | N/A | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 10/7/2024 |
DNLI Denali Therapeutics | $21.45
-0.2% | 10/7/2024 | Downgraded by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Neutral | | High | View details for Cantor Fitzgerald rating of Denali Therapeutics (NASDAQ:DNLI) on 10/7/2024 |
SGRY Surgery Partners | $21.22
+8.2% | 10/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 -> $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 10/4/2024 |
TBRG TruBridge | $18.19
+1.2% | 10/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 10/4/2024 |
BHVN Biohaven | $36.26
+2.6% | 10/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 10/4/2024 |
HCAT Health Catalyst | $7.09
+1.7% | 10/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 -> $16.00 | Medium | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 10/4/2024 |
PAY Payfare | C$2.11
+1.0% | 10/3/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Payfare (TSE:PAY) on 10/3/2024 |
STNE StoneCo | $8.20
+2.5% | 10/3/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of StoneCo (NASDAQ:STNE) on 10/3/2024 |
ROOT Root | $73.22
+3.0% | 10/3/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Root (NASDAQ:ROOT) on 10/3/2024 |
PAGS PagSeguro Digital | $6.40
+2.2% | 10/3/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of PagSeguro Digital (NYSE:PAGS) on 10/3/2024 |
ML MoneyLion | $86.75
-0.1% | 10/3/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Strong-Buy | | High | View details for Cantor Fitzgerald rating of MoneyLion (NYSE:ML) on 10/3/2024 |
KPLT Katapult | $5.92
-7.4% | 10/3/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Hold | | Medium | View details for Cantor Fitzgerald rating of Katapult (NASDAQ:KPLT) on 10/3/2024 |
BITF Bitfarms | $1.68
-0.6% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $5.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 10/3/2024 |
BTDR Bitdeer Technologies Group | $20.49
+13.0% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $13.00 -> $13.00 | Medium | View details for Cantor Fitzgerald rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 10/3/2024 |
CIFR Cipher Mining | $5.73
-0.2% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $9.00 -> $9.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 10/3/2024 |
CLSK CleanSpark | $11.14
+2.1% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $23.00 -> $23.00 | Low | View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 10/3/2024 |
CORZ Core Scientific | $14.13
-2.4% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $20.00 -> $20.00 | Low | View details for Cantor Fitzgerald rating of Core Scientific (NASDAQ:CORZ) on 10/3/2024 |
IREN Iris Energy | $11.81
+3.5% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $20.00 -> $20.00 | Medium | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 10/3/2024 |
RIOT Riot Platforms | $11.55
+3.2% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $22.00 -> $22.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 10/3/2024 |
WULF TeraWulf | $6.61
+1.8% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $10.00 -> $10.00 | High | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 10/3/2024 |
MRK Merck & Co., Inc. | $98.05
-1.5% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $155.00 -> $155.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 10/3/2024 |
PFE Pfizer | $26.36
+2.3% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 10/3/2024 |
RCUS Arcus Biosciences | $15.50
+0.3% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Medium | View details for Cantor Fitzgerald rating of Arcus Biosciences (NYSE:RCUS) on 10/3/2024 |
LASR nLIGHT | $10.09
+2.1% | 10/3/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Siegler | Overweight | $15.50 | Medium | View details for Cantor Fitzgerald rating of nLIGHT (NASDAQ:LASR) on 10/3/2024 |
UHS Universal Health Services | $180.11
+2.5% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Neutral -> Neutral | $219.00 -> $219.00 | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 10/1/2024 |
UNH UnitedHealth Group | $500.13
+2.2% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 -> $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 10/1/2024 |
PGNY Progyny | $14.34
+1.1% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 -> $25.00 | Low | View details for Cantor Fitzgerald rating of Progyny (NASDAQ:PGNY) on 10/1/2024 |
THC Tenet Healthcare | $129.46
+3.0% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $168.00 -> $168.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 10/1/2024 |
ACHC Acadia Healthcare | $37.90
-1.8% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $90.00 -> $90.00 | Low | View details for Cantor Fitzgerald rating of Acadia Healthcare (NASDAQ:ACHC) on 10/1/2024 |
CI The Cigna Group | $276.92
+0.8% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $400.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 10/1/2024 |
CNC Centene | $59.58
-0.2% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 -> $90.00 | Medium | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 10/1/2024 |
CVS CVS Health | $44.36
+1.3% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Neutral -> Neutral | $62.00 -> $62.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 10/1/2024 |
ELV Elevance Health | $365.96
-0.1% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $600.00 -> $600.00 | Medium | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 10/1/2024 |
HCA HCA Healthcare | $303.62
+2.1% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $392.00 -> $392.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 10/1/2024 |
HUM Humana | $247.10
+4.8% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $395.00 -> $395.00 | High | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 10/1/2024 |
